Copenhagen Summer University 2016
 

Copenhagen Summer University 2016

 
Publisert: 16.03.16
Please be aware that the University of Copenhagen for the sixth consecutive year offers a number for executive summer courses in August 2016 for life sciences professionals. More than 1000 participants from around the world have participated in the Copenhagen Summer University progamme over the last years and we think you could be interested in some of the courses listed below:


Market Access for Pharmaceutical Products – trends and challenges

Learn and discuss with international experts on market access and develop your market access strategy that best responds to the demands of ever changing healthcare systems.


Quality by Design (QbD) in Pharmaceutical Development

Quality by Design (QbD) is at the very heart of modern pharmaceutical development. The implementation of QbD principles provides a cost-efficient
approach to delivering high quality medicines for patients. Regulatory authorities, both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), are placing great emphasis on the QbD component as a part of regulatory filing. QbD has become a crucial element in a stream-lined drug development process.


Personalised Medicine – the future treatment paradigm

Personalised medicine is a rapidly developing and growing field. Advances in genomic and clinical science have created innovative opportunities to tailor health care to each patient. Personalised medicine is a strategy based on individual phenotyping of profiles rather than the long established ‘onesize-fits-all’ approach. It is based on a multidisciplinary approach translating advances in basic science and drug discovery and development into clinical practice.


Biopharmaceuticals Drug Development

The complexity of drug development, in particular pharmaceutical development and safety assessment, still poses large challenges in the overall development of novel biopharmaceuticals. This course provides an interdisciplinary introduction to the newest advances in our ability to develop effective biopharmaceuticals.
<< Forrige        50 av 80        Neste >>